We found that breast and ovarian cancer patients with high expression levels of SOCS3 were resistant to chemotherapy; however, GBM and colorectal cancer patients with high expression levels of SOCS3 were more sensitive to chemotherapy than patients with low SOCS3 expression (Figure 11A). The gene discussed is SOCS3; the disease is colorectal cancer.